Evidence map›Paper›PMID 26269750›Full record

ArticleAmerican journal of cancer research2015

PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma.

Shaolin Tao, Jie Yu, Yi Xu, Bo Deng, Tianyu Sun, Pingping Hu, Zhuanqin Wei, Jingge Zhang, Ruwen Wang, Chunmeng Shi and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Shaolin TaoDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Jie YuDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Yi XuDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Bo DengDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Tianyu SunDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Pingping HuDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Zhuanqin WeiDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Jingge ZhangDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Ruwen WangDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Chunmeng ShiInstitute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, College of Preventive Medicine, Third Military Medical University Chongqing 400038, P. R. China.
Qunyou TanDepartment of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, The Third Military Medical University Chongqing 400038, P. R. China.
Army Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human transcriptional positive cofactor 4 (PC4) is a novel marker for diagnosis and treatment of advanced human cancers metastasis. In human lung adenocarcinoma, tumor lymphangiogenesis, an important early event, can promotes lymphatic metastasis, while it has been reported that VEGF-C/VEGF-D/VEGFR-3 axis plays an important role in lymphangiogenesis. The proposed study aims to explore whether PC4 correlates with VEGF-C/VEGF-D/VEGFR-3 axis of lymphangiogenesis in the lymph node metastasis during lung adenocarcinoma. Here, small interfering RNA technique was employed to investigate the relationship of PC4 and the VEGF-C/VEGF-D/VEGFR-3 axis in lung adenocarcinoma cell lines as well as tumor xenografts of mice model. And then mRNA and protein levels of PC4, VEGF-C, VEGF-D and VEGFR-3 were analyzed. Moreover, the correlation between PC4 expression and lymphatic vessel density or the rate of metastatsis in vivo was also revealed. Down-regulating PC4 expression resulted in the lower expression of VEGFC, VEGF-D and VEGFR-3 in mRNA and protein levels, and PC4 expression was significantly related with the factor of VEGF-C/VEGF-D/VEGFR-3 axis expression (P<0.05). Meanwhile, high expression level of PC4 was accompanied by the higher density of tumor lymphatic vessels and the rate of metastatsis in vivo (P<0.05). PC4 expression correlated with the levels of VEGF-C, VEGF-D and VEGFR-3 during the development of lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma in vitro and in vivo, which may be a novel marker in the development of lymphangiogenesis and lymphatic metastasis of tumors.

Indexed as

lung adenocarcinomalymphangiogenesismetastasisPC4VEGF-C/VEGF-D/VEGFR-3 axis

Identifiers

PMID26269750
PMCPMC4529610
OpenAlexW1596095139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.